Delivery Order SPE2DB20D2104-SPE2DB22FS47V
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,539.45, is for the delivery of Vascepa 1 GM capsules. It is a firm-fixed price delivery order contract with a period of performance through March 13, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in pharmaceutical distribution and medical supply procurement for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vascepa 1 GM Capsule 120S. The contract, valued at $27,009.35, is a delivery order under a larger Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as a primary vehicle for Cencora, Inc. to provide a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Vascepa 1 GM capsules, a cardiovascular medication, with a ceiling value of $1,732.01. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 11, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,933.49 firm fixed price delivery order is for the supply of VASCEPA 1 GM capsules. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare...
- This federal contract award, valued at $1,335.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the pharmaceutical product VASCEPA 1 GM CAPSULE 120S, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,023.88, is a delivery order for the supply of the medication Vascepa 1 GM Capsule 120S. The contract has a firm fixed price and an ultimate completion date of January 21, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VASCEPA 1 GM CAPSULE 120S. The $1,519.81 firm fixed-price delivery order was awarded on December 3, 2021, with a completion date of December 6, 2021. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vascepa 1 GM Capsule 120S. The contract, valued at $4,480.14, is a firm fixed-price delivery order with a completion date of February 15, 2023. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $15,047.32 delivery order contract is for the supply of VASCEPA 1 GM capsules, a cardiovascular medication. The contract is a firm fixed-price, Delivery Order type with an ultimate completion date of October 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also...
- This federal contract award, valued at $4,567.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FS47VDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vascepa 1 GM capsules. The contract has a ceiling value of $11,059.33 and an ultimate completion date of April 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 4/21/22 |